Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04450836
Title Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer (SOREGATT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications

colon adenocarcinoma

colorectal cancer

rectum adenocarcinoma

Therapies

Regorafenib + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.